A Phase 2b Long-Term, Randomized, Open-Label, Safety And Tolerability Trial Comparing [S,S]-Reboxetine (PNU-165442g) With Routine Care In Patients With Chronic Painful Diabetic Peripheral Neuropathy (DPN).
A Phase 2b Long-Term, Randomized, Open-Label, Safety And Tolerability Trial Comparing [S,S]-Reboxetine (PNU-165442g) With Routine Care In Patients With Chronic Painful Diabetic Peripheral Neuropathy (DPN).
The purpose of this study is to assess the long-term safety and tolerability of [S,S]-Reboxetine in patients with chronic painful diabetic peripheral neuropathy
Inclusion Criteria:
Exclusion Criteria:
Honululu, Hawaii 96814, United States
Viljandi Mk., 71024, Estonia
St.Ingbert, 66386, Germany
Tann I.d. Rhoen, 36142, Germany
Hyderabad, Andhra Pradesh 500 033, India
Maharashtra, Mumbai 400 007, India
Houghton, Johannesburg, 2198, South Africa